From AI to Musk’s Brain Chip, the F.D.A.’s Device Unit Faces Rapid Change

Published On Nov 1, 2024, 11:12 AM

The article discusses the recent appointment of Dr. Michelle Tarver as the director of the FDA’s medical device division, amid rising concerns over the rapid approvals of innovative medical technologies such as brain-computer interfaces. These advancements, including devices that help paralyzed individuals regain speech or movement, represent both significant progress and potential regulatory challenges. Key issues include maintaining device safety standards and addressing ethical concerns regarding the influence of the device industry.

Read full article

Stock Forecasts

TSLAView TSLA chart on TradingView

Positive

With the increasing focus on brain-computer interfaces and the potential for FDA scrutiny of emerging technologies, companies involved in this space may see growth. Major players like Neuralink, along with companies developing similar technologies, may benefit from heightened interest in their innovations. However, regulatory challenges could create volatility.

Related News

U.S. Factory Towns Laid Low by the ‘China Shock’ Are Benefiting From New Investments

Nov 1, 2024, 5:03 AM

Communities that suffered the worst of plant closings in recent decades are now gaining an outsize share of fresh investment and new jobs.

TSLA
XLI

Why a Memphis Community Is Fighting Elon Musk’s Supercomputer

Oct 31, 2024, 11:07 AM

Residents say Mr. Musk’s data center for artificial intelligence is compounding their pollution burden and adding stress on the local electrical grid.

TSLA

Will Tesla's Cybercab electrify the stock?

Oct 30, 2024, 11:25 AM

Tesla investors are looking for new avenues for growth.

TSLA